Delivery Order SPE2DB22D2009-SPE2DB25FM0WX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,106.16 to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count packages) with a ceiling value of $1,150.23. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance of this contract is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg with a ceiling value of $3,774.96. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mucus Relief ER 600 mg tablets (500-count bottles) with a ceiling value of $1,195.33 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets in a quantity of 500 units, with a contract ceiling value of $1,206.30. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,641.44. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $965 to Amerisourcebergen Drug Corporation for Mucus Relief ER 600 mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 500 tablets to a facility located in Conshohocken, Pennsylvania, with performance required from July 11-12, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen frequently supports the Defense Logistics...
- The Defense Logistics Agency awarded a $524.70 firm fixed price delivery order to Amerisourcebergen Drug Corp for 500 boxes of 600mg Mucus Relief ER tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by July 3, 2023 to support DLA's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp. No subcontractors or set aside designations were identified in the...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0WXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, valued at $2,271.04, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime indefinite delivery vehicle enables the company to supply pharmaceutical products, generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs. The company has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, positioning it as a key supplier within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/13/25 |